thymoquinone has been researched along with Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Malki, AL; AlGhamdi, AA; Choudhry, H; Khan, MI; Mohammed, MRS; Qari, MH; Zamzami, MA | 1 |
| Abdulla, MA; Al-Jashamy, K; Ali, HM; Dehghan, F; Hassandarvish, P; Ibrahim, MY; Mohan, S; Omer, FA; Othman, R; Salim, LZ | 1 |
2 other study(ies) available for thymoquinone and Leukemia
| Article | Year |
|---|---|
Untargeted Metabolomics Identifies Key Metabolic Pathways Altered by Thymoquinone in Leukemic Cancer Cells.
Topics: Apoptosis; Benzoquinones; Cell Line, Tumor; Humans; Leukemia; Metabolic Networks and Pathways; Metabolomics | 2020 |
Thymoquinone inhibits murine leukemia WEHI-3 cells in vivo and in vitro.
Topics: Animals; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Benzoquinones; Body Weight; Cell Line, Tumor; Down-Regulation; HSP70 Heat-Shock Proteins; Killer Cells, Natural; Leukemia; Liver; Mice; Mice, Inbred BALB C; Nigella sativa; Organ Size; Proto-Oncogene Proteins c-bcl-2; S Phase Cell Cycle Checkpoints; Spleen; Transplantation, Homologous; Up-Regulation | 2014 |